We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-6.88%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.39B
AUM Growth
-$1.88B
Cap. Flow
-$1.67B
Cap. Flow %
-49.21%
Top 10 Hldgs %
42.09%
Holding
110
New
24
Increased
17
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$163M
2
NXPI icon
NXP Semiconductors
NXPI
+$72.5M
3
PTCT icon
PTC Therapeutics
PTCT
+$72M
4
CI icon
Cigna
CI
+$64.7M
5
SAGE
Sage Therapeutics
SAGE
+$62.5M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$217M
2
HUM icon
Humana
HUM
+$149M
3
ICUI icon
ICU Medical
ICUI
+$97.4M
4
BABA icon
Alibaba
BABA
+$84.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$83.1M

Sector Composition

Rank Sector Weight
1 Healthcare 59.59%
2 Technology 15.32%
3 Financials 1.11%
4 Communication Services 1.02%
5 Consumer Discretionary 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
76
Elevance Health
ELV
$81.5B
– –
-189,219
Closed -$53.4M
ESPR
77
DELISTED
Esperion Therapeutics
ESPR
– –
-1,555,112
Closed -$72.3M
EXAS
78
DELISTED
Exact Sciences
EXAS
– –
-418,329
Closed -$49.4M
FICO icon
79
Fair Isaac
FICO
$24.3B
– –
-56,215
Closed -$17.7M
HUM icon
80
Humana
HUM
$43.7B
– –
-562,177
Closed -$149M
ICUI icon
81
ICU Medical
ICUI
$4.21B
– –
-386,592
Closed -$97.4M
INGN icon
82
Inogen
INGN
$175M
– –
-141,077
Closed -$9.42M
MMSI icon
83
Merit Medical Systems
MMSI
$5.08B
– –
-444,187
Closed -$26.5M
MSGS icon
84
Madison Square Garden
MSGS
$9.48B
– –
-143,520
Closed -$28.7M
NFLX icon
85
Netflix
NFLX
$299B
– –
-1,056,390
Closed -$38.8M
NYT icon
86
New York Times
NYT
$12.1B
– –
-1,301,486
Closed -$42.5M
OEF icon
87
PUT
iShares S&P 100 ETF
OEF
$20.1B
– –
-1,115,500
Closed -$47.9M
PCRX icon
88
Pacira BioSciences
PCRX
$1.04B
– –
-734,346
Closed -$31.9M
PFE icon
89
CALL
Pfizer
PFE
$143B
– –
-1,394,020
Closed -$57.3M
PFE icon
90
Pfizer
PFE
$143B
– –
-1,720,850
Closed -$70.7M
PGR icon
91
Progressive
PGR
$123B
– –
-653,485
Closed -$52.2M
QCOM icon
92
CALL
Qualcomm
QCOM
$155B
– –
-1,538,900
Closed -$117M
QQQ icon
93
PUT
Invesco QQQ Trust
QQQ
$453B
– –
-3,787,600
Closed -$707M
RVTY icon
94
Revvity
RVTY
$12.6B
– –
-213,370
Closed -$20.6M
SE icon
95
Sea Limited
SE
$65.4B
– –
-1,155,123
Closed -$38.4M
SRPT icon
96
Sarepta Therapeutics
SRPT
$1.57B
– –
-546,786
Closed -$83.1M
TCOM icon
97
Trip.com Group
TCOM
$29.6B
– –
-927,160
Closed -$34.2M
THC icon
98
Tenet Healthcare
THC
$20.5B
– –
-1,484,683
Closed -$30.7M
TMO icon
99
Thermo Fisher Scientific
TMO
$213B
– –
-160,666
Closed -$47.2M
UNH icon
100
UnitedHealth
UNH
$376B
– –
-61,321
Closed -$15M
1 2 3
4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q3 2019 Portfolio in Review

As of Q3 2019, PFM Health Sciences held 110 positions worth $3.39B, down 36% from $5.26B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

PFM Health Sciences withdrew a net $1.67B in Q3 2019, closing 38 positions and reducing 27 holdings. Its most notable exit was Humana, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

Against the trend, PFM Health Sciences opened a new position in Alexion Pharmaceuticals worth $142M.

  • PFM Health Sciences's largest Q3 2019 buy was Alexion Pharmaceuticals: 1,446,612 shares worth $142M.
  • PFM Health Sciences added most to uniQure in Q3 2019, an estimated $56.8M increase.
  • PFM Health Sciences's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $217M.
  • PFM Health Sciences fully exited Humana in Q3 2019, selling an estimated $149M.
  • PFM Health Sciences's ten largest holdings make up 42% of its $3.39B portfolio in Q3 2019.
  • PFM Health Sciences opened 24 new positions and closed 38 in Q3 2019.
  • PFM Health Sciences's portfolio value fell 36% quarter-over-quarter to $3.39B.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.